Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Accuray Incorporated stock | $3.93

Learn how to easily invest in Accuray Incorporated stock.

Accuray Incorporated is a medical devices business based in the US. Accuray Incorporated shares (ARAY) are listed on the NASDAQ and all prices are listed in US Dollars. Accuray Incorporated employs 995 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Accuray Incorporated

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ARAY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Accuray Incorporated stock price (NASDAQ: ARAY)

Use our graph to track the performance of ARAY stocks over time.

Accuray Incorporated shares at a glance

Information last updated 2021-10-17.
Latest market close$3.93
52-week range$2.77 - $6.02
50-day moving average $3.84
200-day moving average $4.29
Wall St. target price$8.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.07

Buy Accuray Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Accuray Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Accuray Incorporated price performance over time

Historical closes compared with the close of $3.93 from 2021-10-15

1 week (2021-10-12) -2.48%
1 month (2021-09-17) 5.36%
3 months (2021-07-19) 0.51%
6 months (2021-04-19) -23.84%
1 year (2020-10-19) 20.92%
2 years (2019-10-18) 47.74%
3 years (2018-10-19) 8.86%
5 years (2016-10-19) 5.5

Is Accuray Incorporated under- or over-valued?

Valuing Accuray Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Accuray Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Accuray Incorporated's PEG ratio

Accuray Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.08. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Accuray Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Accuray Incorporated's EBITDA

Accuray Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.6 million.

The EBITDA is a measure of a Accuray Incorporated's overall financial performance and is widely used to measure a its profitability.

Accuray Incorporated financials

Revenue TTM $396.3 million
Operating margin TTM 5.61%
Gross profit TTM $159.5 million
Return on assets TTM 2.86%
Return on equity TTM -9.53%
Profit margin -1.59%
Book value $0.76
Market capitalisation $357.1 million

TTM: trailing 12 months

Shorting Accuray Incorporated shares

There are currently 8.0 million Accuray Incorporated shares held short by investors – that's known as Accuray Incorporated's "short interest". This figure is 8% down from 8.7 million last month.

There are a few different ways that this level of interest in shorting Accuray Incorporated shares can be evaluated.

Accuray Incorporated's "short interest ratio" (SIR)

Accuray Incorporated's "short interest ratio" (SIR) is the quantity of Accuray Incorporated shares currently shorted divided by the average quantity of Accuray Incorporated shares traded daily (recently around 835661.49843913). Accuray Incorporated's SIR currently stands at 9.61. In other words for every 100,000 Accuray Incorporated shares traded daily on the market, roughly 9610 shares are currently held short.

However Accuray Incorporated's short interest can also be evaluated against the total number of Accuray Incorporated shares, or, against the total number of tradable Accuray Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accuray Incorporated's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Accuray Incorporated shares in existence, roughly 90 shares are currently held short) or 0.0965% of the tradable shares (for every 100,000 tradable Accuray Incorporated shares, roughly 97 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Accuray Incorporated.

Find out more about how you can short Accuray Incorporated stock.

Accuray Incorporated share dividends

We're not expecting Accuray Incorporated to pay a dividend over the next 12 months.

Accuray Incorporated share price volatility

Over the last 12 months, Accuray Incorporated's shares have ranged in value from as little as $2.77 up to $6.015. A popular way to gauge a stock's volatility is its "beta".

ARAY.US volatility(beta: 1.85)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accuray Incorporated's is 1.8503. This would suggest that Accuray Incorporated's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Accuray Incorporated overview

Accuray Incorporated develops, manufactures, and sells radiotherapy systems for alternative cancer treatments in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California. .

Frequently asked questions

What percentage of Accuray Incorporated is owned by insiders or institutions?
Currently 3.754% of Accuray Incorporated shares are held by insiders and 79.519% by institutions.
How many people work for Accuray Incorporated?
Latest data suggests 995 work at Accuray Incorporated.
When does the fiscal year end for Accuray Incorporated?
Accuray Incorporated's fiscal year ends in June.
Where is Accuray Incorporated based?
Accuray Incorporated's address is: 1310 Chesapeake Terrace, Sunnyvale, CA, United States, 94089
What is Accuray Incorporated's ISIN number?
Accuray Incorporated's international securities identification number is: US0043971052
What is Accuray Incorporated's CUSIP number?
Accuray Incorporated's Committee on Uniform Securities Identification Procedures number is: 004397105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site